We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Affiliated Managers Group
AMG
$8.87B
| $1.12M | ﹤0.01% |
7,473
-143
| -2% | -$20.5K |
|
|
QVCGA
1102
DELISTED
QVC Group Inc Series A
QVCGA
| $1.12M | ﹤0.01% |
22,591
+368
| +2% | +$16.6K |
|
1103
Chemed
CHE
$6.66B
| $1.11M | ﹤0.01% |
2,055
-391
| -16% | -$214K |
|
1104
ITT
ITT
$17.4B
| $1.11M | ﹤0.01% |
11,935
-408
| -3% | -$34.3K |
|
1105
Fox Class A
FOXA
$27.8B
| $1.11M | ﹤0.01% |
32,664
+6,359
| +24% | +$208K |
|
1106
Saia
SAIA
$9.14B
| $1.11M | ﹤0.01% |
3,234
-59
| -2% | -$17.1K |
|
1107
Financial Institutions
FISI
$793M
| $1.1M | ﹤0.01% |
70,182
| – | – |
|
|
NUVA
1108
DELISTED
NuVasive, Inc.
NUVA
| $1.1M | ﹤0.01% |
26,458
+25,398
| +2,396% | +$1.04M |
|
1109
EOG Resources
EOG
$76B
| $1.09M | ﹤0.01% |
9,520
+1,674
| +21% | +$191K |
|
1110
KBR
KBR
$4.61B
| $1.08M | ﹤0.01% |
16,664
-362
| -2% | -$21.6K |
|
1111
Amalgamated Financial
AMAL
$1.39B
| $1.07M | ﹤0.01% |
66,761
-533,564
| -89% | -$8.57M |
|
|
LENZ
1112
LENZ Therapeutics
LENZ
$130M
| $1.06M | ﹤0.01% |
58,308
-258
| -0.4% | -$5.16K |
|
1113
Corebridge Financial
CRBG
$15.5B
| $1.06M | ﹤0.01% |
59,941
+5,525
| +10% | +$92.2K |
|
1114
Jones Lang LaSalle
JLL
$15.7B
| $1.05M | ﹤0.01% |
6,734
+869
| +15% | +$123K |
|
1115
Lennar Class A
LEN
$18.9B
| $1.05M | ﹤0.01% |
8,636
+7,231
| +515% | +$789K |
|
1116
Digital Turbine
APPS
$1.31B
| $1.05M | ﹤0.01% |
112,673
-594,628
| -84% | -$6.55M |
|
1117
Brixmor Property Group
BRX
$8.59B
| $1.04M | ﹤0.01% |
47,416
-9,910
| -17% | -$207K |
|
1118
Tennant Co
TNC
$1.16B
| $1.04M | ﹤0.01% |
12,849
-4,601
| -26% | -$346K |
|
1119
UFP Industries
UFPI
$4.52B
| $1.04M | ﹤0.01% |
10,735
-540
| -5% | -$45K |
|
1120
Comtech Telecommunications
CMTL
$44.6M
| $1.04M | ﹤0.01% |
113,985
-41
| -0% | -$440 |
|
|
PRMW
1121
DELISTED
Primo Water Corporation
PRMW
| $1.03M | ﹤0.01% |
81,900
-14
| -0% | -$196 |
|
1122
First Horizon
FHN
$11.3B
| $1.03M | ﹤0.01% |
91,019
+13,493
| +17% | +$181K |
|
1123
MasTec
MTZ
$18.1B
| $1.02M | ﹤0.01% |
8,673
-114
| -1% | -$11.2K |
|
1124
Valmont Industries
VMI
$9.18B
| $1.02M | ﹤0.01% |
3,509
-77
| -2% | -$22.2K |
|
1125
Sun Communities
SUI
$14B
| $1.02M | ﹤0.01% |
7,791
-1,857
| -19% | -$248K |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.